Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1995-05-30
1997-06-10
Azpuru, Carlos
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
424451, 424456, 424464, 514169, 514172, 514173, 514177, 514178, 514179, 514180, 514181, 514182, 514319, 514428, 514462, A61F 202, A61K 920, A61K 3156, A61K 3158
Patent
active
056373104
ABSTRACT:
Invented is a Method of Treating Prostatic Adenocarcinoma by employing asteroid 5-.alpha.-reductase inhibiting compound or a combination of steroid 5-.alpha.-reductase inhibiting compounds.
REFERENCES:
patent: 4882319 (1989-11-01), Holt et al.
patent: 4910226 (1990-03-01), Holt et al.
patent: 4937237 (1990-06-01), Holt et al.
patent: 4946834 (1990-08-01), Holt et al.
patent: 4970205 (1990-11-01), Holt et al.
patent: 5017568 (1991-05-01), Holt et al.
patent: 5032586 (1991-07-01), Holt et al.
patent: 5041433 (1991-08-01), Holt et al.
patent: 5137882 (1992-08-01), Holt et al.
J. Natl Cancer Inst; 74(2) pp. 475-486 (1985).
The Urologic Clinics of North America; vol. 18, No. 1 pp. 93-98 (1991).
Progress in Cancer Research Therapy; vol. 31, No. 2 pp. 477-489 (1984).
J. Med. Chem.; vol. 33, No. 3, pp. 937-942 (1990).
J. Med. Chem.; vol. 33, No. 3, pp. 943-950 (1990).
J. Steroid Biochem; vol. 34, Nos. 1-6, pp. 571-575 (1989).
The Prostate; 18, pp. 215-227 (1991).
J. Steroid Biochem; 24, pp. 887-886 (1986).
Bio Chemistry; 28, pp. 140-148 (1989).
Endocrinology, 117 No. 2, pp. 571-579 (1985).
Academic Press, Inc, CH 8 V, pp. 269-304 (1984).
Azpuru Carlos
Dustman Wayne J.
Kinzig Charles M.
Lentz Edward T.
SmithKline Beecham Corporation
LandOfFree
Method of treating prostatic adenocarcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating prostatic adenocarcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating prostatic adenocarcinoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-763010